| 1 |
21625009 | A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice. | 2011 Aug |
1 |
| 2 |
17604873 | Point mutation of K-ras gene in cisplatin-induced lung tumours in A/J mice. | 2007 Oct |
1 |
| 3 |
11195470 | Chemopreventive efficacy of promising farnesyltransferase inhibitors. | 2000 Dec |
2 |
| 4 |
9133601 | Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice. | 1997 Apr 1 |
1 |
| 5 |
8609047 | Effects of K-ras gene mutations in the development of lung lesions induced by 4-(N-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone in A/J mice. | 1996 Jan |
1 |
| 6 |
7586156 | K-ras mutations in lung tumors from A/J and A/J x TSG-p53 F1 mice treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and phenethyl isothiocyanate. | 1995 Oct |
1 |
| 7 |
7916989 | Ki-ras mutations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-initiated and butylated hydroxytoluene-promoted lung tumors in A/J mice. | 1994 Sep |
1 |
| 8 |
7902220 | G to A transitions and G to T transversions in codon 12 of the Ki-ras oncogene isolated from mouse lung tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and related DNA methylating and pyridyloxobutylating agents. | 1993 Nov |
2 |